Skip to main content
. 2018 Aug 31;104(2):305–311. doi: 10.3324/haematol.2018.191148

Figure 1.

Figure 1.

Persistent IDH1/2 mutations in remission and changes in mutant allelic frequencies in pretreatment and remission samples. (A) Percentages of persistent IDH1/2 mutations in patients with acute myeloid leukemia in remission. Persistent mutations occur at similar frequencies for the different mutations. (B) Mutant allelic frequency (MAF) of IDH mutations present in pretreatment samples and remission samples. The median mutant allelic frequency is shown for each occasion.